Invesaro

Stocks Comparison

Tilray Brands vs Usana Health Sciences: revenue, profit, margins and growth compared

Tilray Brands brought in $915.5M of revenue in fiscal 2026, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by +11.5% at Tilray Brands and +8.3% at Usana Health Sciences on the year before, so Tilray Brands grew faster. Tilray Brands kept -13.3% of its revenue as net profit, Usana Health Sciences 1.2%.

Side by side, latest fiscal year

TLRYUSNA
Fiscal year endedFY2026 (May 31, 2026)FY2025 (January 3, 2026)
Revenue$915.5M$925.3M
Revenue growth+11.5%+8.3%
Net income-$121.4M$10.8M
Net margin-13.3%1.2%
Free cash flown/a$8.5M
Free cash flow marginn/a0.9%
Earnings per share (diluted)-$1.09$0.58
Cash$226M$158.4M
Debtn/an/a
Price to earningsn/a25.0
Market value$481.2M$267.9M
Dividend yieldn/an/a
Rank by revenue in sector#151 of 523 · Health care#150 of 523 · Health care

Over the years

Revenue
TLRY FY2021: $405.3MTLRY FY2020: $210.5MTLRY FY2021: $513.1MTLRY FY2022: $628.4MTLRY FY2023: $627.1MTLRY FY2024: $788.9MTLRY FY2025: $821.3MTLRY FY2026: $915.5MUSNA FY2018: $1.2BUSNA FY2019: $1.1BUSNA FY2020: $1.1BUSNA FY2022: $1.2BUSNA FY2022: $998.6MUSNA FY2023: $921MUSNA FY2023: $854.5MUSNA FY2025: $925.3MFY18FY19FY20FY21FY22FY23FY24FY25FY26
TLRY $915.5MUSNA $925.3M
Net income
TLRY FY2021: -$102.5MTLRY FY2020: -$271.1MTLRY FY2021: -$367.4MTLRY FY2022: -$476.8MTLRY FY2023: -$1.5BTLRY FY2024: -$245MTLRY FY2025: -$2.2BTLRY FY2026: -$121.4MUSNA FY2018: $126.2MUSNA FY2019: $100.5MUSNA FY2020: $124.7MUSNA FY2022: $116.5MUSNA FY2022: $69.4MUSNA FY2023: $63.8MUSNA FY2023: $42MUSNA FY2025: $10.8MFY18FY19FY20FY21FY22FY23FY24FY25FY26
TLRY -$121.4MUSNA $10.8M
Net margin
TLRY FY2021: -25.3%TLRY FY2020: -128.8%TLRY FY2021: -71.6%TLRY FY2022: -75.9%TLRY FY2023: -231.6%TLRY FY2024: -31.1%TLRY FY2025: -266.3%TLRY FY2026: -13.3%USNA FY2018: 10.6%USNA FY2019: 9.5%USNA FY2020: 11.0%USNA FY2022: 9.8%USNA FY2022: 6.9%USNA FY2023: 6.9%USNA FY2023: 4.9%USNA FY2025: 1.2%FY18FY19FY20FY21FY22FY23FY24FY25FY26
TLRY -13.3%USNA 1.2%
Revenue growth
TLRY FY2020: -48.1%TLRY FY2021: +143.8%TLRY FY2022: +22.5%TLRY FY2023: -0.2%TLRY FY2024: +25.8%TLRY FY2025: +4.1%TLRY FY2026: +11.5%USNA FY2019: -10.8%USNA FY2020: +7.0%USNA FY2022: +4.6%USNA FY2022: -15.8%USNA FY2023: -7.8%USNA FY2023: -7.2%USNA FY2025: +8.3%FY19FY20FY21FY22FY23FY24FY25FY26
TLRY +11.5%USNA +8.3%
Free cash flow
TLRY FY2021: -$199.4MTLRY FY2020: -$174MTLRY FY2021: -$83.6MTLRY FY2022: -$211.3MTLRY FY2023: -$12.9MTLRY FY2024: -$60.2MTLRY FY2025: -$127.5MUSNA FY2018: $140.7MUSNA FY2019: $110.2MUSNA FY2020: $145.3MUSNA FY2022: $108.5MUSNA FY2022: $93.5MUSNA FY2023: $56.1MUSNA FY2023: $50.9MUSNA FY2025: $8.5MFY18FY19FY20FY21FY22FY23FY24FY25
TLRY -$127.5MUSNA $8.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Tilray Brands and Usana Health Sciences

Which is bigger by revenue, Tilray Brands or Usana Health Sciences?

Usana Health Sciences is bigger by revenue: $925.3M in fiscal 2025, against $915.5M for Tilray Brands in fiscal 2026.

Which keeps more of its revenue as profit, Tilray Brands or Usana Health Sciences?

Tilray Brands had a net margin of -13.3% in fiscal 2026; Usana Health Sciences had 1.2% in fiscal 2025.

Which grew revenue faster, Tilray Brands or Usana Health Sciences?

In their latest fiscal years revenue changed by +11.5% at Tilray Brands and +8.3% at Usana Health Sciences.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies